I

Inspira Mental Health Management | Inspira Clinical Research

Research site
(Unclaimed)
Location
405 Hostos Avenuve, San Juan, Puerto Rico, United States of America
Site insights

Top conditions

Depression (9 trials)

Depressive Disorder (8 trials)

Major Depressive Disorder (6 trials)

Alzheimer Disease (4 trials)

Schizophrenia (2 trials)

Top treatments

Cariprazine
Donanemab
Lurasidone
SPD489
Agomelatine
LY3002813
Rivastigmine
Simufilam
Levomilnacipran

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Trials

3 of 15
Status: Active
Trial type: Interventional
Funder type: Industry

Filters
3
A Donanemab (LY3002813) Prevention Study in Participants With Alzheimer's Disease (TRAILBLAZER-ALZ 3)

The main purpose of this study is to evaluate the safety and efficacy of donanemab in participants with preclinical Alzheimer's Disease (AD).

Enrolling
Alzheimer Disease
Drug: Donanemab
Drug: Placebo

The reason for this study is to see how safe and effective the study drug donanemab is in participants with early Alzheimer's disease.Additional part...

Active, not recruiting
Alzheimer Disease
Drug: Donanemab
Drug: Placebo

A 76-week safety and efficacy study of simufilam (PTI-125) given twice daily to participants with mild-to-moderate Alzheimer's disease (AD) for 76 we...

Active, not recruiting
Alzheimer Disease
Drug: Placebo
Drug: Simufilam

Trial sponsors

AbbVie logo

AbbVie (3 trials)

Clinical trials

Find clinical trialsTrials by location

Resources

© Copyright 2024 Veeva Systems